N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma

By sjmartinez • July 27, 2024

Geroyska S, Mejia I, Chan AA, Navarrete M, Pandey V, Kharpatin S, Noguti J, Wang F, Srole D, Chou TF, Wohlschlegel J, Nemeth E, Damoiseaux R, Shackelford DB, Lee DJ, Díaz B. N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma. Cancer Res Commun. 2024 Jul 1;4(7):1815-1833. doi: 10.1158/2767-9764.CRC-23-0428. PMID: 38949950; PMCID: PMC11270646.

Tags: Dermatology, Harbor UCLA, Hematology/Oncology, Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

A review of the indications, safety, and efficacy of deucravacitinib: An expert consensus panel

Shah M, DeBusk L, Bohman MH, Rosenberg A, Burshtein J, Zakria D, Armstrong A, Boh E, Gottlieb AB, Khattri S, Litchman G, Merola J, Murina[...]

The efficacy and safety of interleukin-17 and interleukin-23 inhibitors in psoriatic arthritis across multiple disease domains

Zakria D, Shah M, Rosenberg A, Burshtein J, DeBusk L, Altman DA, Armstrong AW, Gottlieb AB, Han G, Khattri S, Shaigany S, Weinberg JM, Lebwohl[...]

Vitiligo in the United States: A 10-year study of patient characteristics, comorbidities, and treatment patterns

Huang MY, Smart K, Lee K, Kingston P, Yee D, Peterson H, Korouri E, Armstrong AW. Vitiligo in the United States: A 10-year study of[...]